NetworkNewsBreaks

WednesdayMay 07, 2025 11:17 am

NetworkNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Join D. Boral Capital Global Conference in New York

Disseminated on behalf of SolarBank Corporation  SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) today announced it will participate in the D. Boral Capital Inaugural Global Conference on May 14, 2025, at The Plaza Hotel in New York City. CEO Dr. Richard Lu will be available for one-on-one investor meetings from 9 a.m. to 3 p.m. ET.  To view the full press release, visit https://nnw.fm/GJNJt  About SolarBank Corporation  SolarBank Corporation is an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the USA . The Company develops solar, Battery Energy Storage System (BESS) and…

Continue Reading

TuesdayMay 06, 2025 11:56 am

NetworkNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Secures Up to $100 Million in Project Financing for 97 MW U.S. Solar Portfolio 

Disseminated on behalf of SolarBank Corporation  SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) has entered into a mandate letter with CIM Group to secure up to $100 million in project-level preferred equity financing for 97 MW of solar power projects in the U.S. The financing, structured through a joint venture with SolarBank subsidiary Abundant Solar Power Inc., will not involve the issuance of new SolarBank shares. CIM will acquire non-convertible preferred equity in the venture, with SolarBank retaining majority ownership of the 21 projects. The deal includes a revenue-sharing model, tax credit transfers, and redemption rights after a five-year…

Continue Reading

TuesdayMay 06, 2025 11:44 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Adds Two U.S. Patents to Bolster Cardiac Monitoring IP Portfolio 

HeartBeam (NASDAQ: BEAT), a medical technology company advancing personalized cardiac care, announced the issuance of two new U.S. patents that strengthen its intellectual property position. The first patent covers the company’s credit card-sized, cable-free 3D ECG device, which enables real-time cardiac monitoring and symptom capture. The second patent protects its rhythm analysis algorithm, which identifies arrhythmias using continuous signal input and prompts users to collect 3D ECG data when anomalies are detected. These additions expand HeartBeam’s patent count to 20 issued and 34 others pending or allowed, reinforcing its platform ahead of future product extensions and FDA review of its…

Continue Reading

TuesdayMay 06, 2025 10:50 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Bollinger Delivers EV Truck to LES Ecology Center

Mullen Automotive (NASDAQ: MULN) announced that its subsidiary, Bollinger Motors, has delivered a Bollinger B4 all-electric Class 4 commercial vehicle to the Lower East Side Ecology Center in New York City. Funded by the NYC Council, the truck will support composting and environmental programs as the LES Ecology Center’s first EV. The B4, equipped with a 158-kWh battery, 185-mile range, and a 16-foot dry box with power lift gate, is designed for urban operations and sustainability-focused fleets. To view the full press release, visit https://nnw.fm/goiKC About Mullen Automotive Inc. Mullen Automotive is a Southern California-based automotive company building the next…

Continue Reading

TuesdayMay 06, 2025 10:40 am

NetworkNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) CEO to Present Live via Skyline Signature Series on May 7

FingerMotion (NASDAQ: FNGR), a mobile services, data and technology company, announced that CEO Martin J. Shen will deliver a live corporate presentation on Wednesday, May 7, at 12 p.m. ET as part of the Skyline Signature Series. The virtual event, hosted by Skyline Corporate Communications Group, will include a live Q&A session following the presentation, allowing financial professionals to engage directly with company leadership. To view the full press release, visit https://nnw.fm/UjcCE About FingerMotion Inc. FingerMotion is an evolving technology company with a core competency in mobile payment and recharge platform solutions in China. As the user base of its…

Continue Reading

TuesdayMay 06, 2025 10:20 am

NetworkNewsBreaks – NextPlat Corp (NASDAQ: NXPL) to Announce Q1 2025 Results on May 15, Hosts Investor Call at 8:30 a.m.

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, will release its financial results for the quarter ended March 31, 2025, before market open on May 15. Management will host a conference call at 8:30 a.m. EDT the same day, led by Executive Chairman and CEO Charles M. Fernandez, CFO Cecile Munnik, and President and CEO of Global Operations David Phipps. To view the full press release, visit: https://nnw.fm/Hlmit About NextPlat Corp NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the company intends…

Continue Reading

TuesdayMay 06, 2025 10:10 am

NetworkNewsBreaks – Authentic Holdings (OTC: AHRO) Subsidiary Maybacks Launches iDreamCTV App to 180 Million Global Users via Whale TV

Authentic Holdings (OTC: AHRO), through its subsidiary Maybacks Global Entertainment, has launched the iDreamCTV App in partnership with Whale TV, reaching over 180 million users across smart TVs and digital devices worldwide. The app features integrated FAST channel content and VAST tag advertising, enabling revenue-sharing with global CTV/OTT ad partners. Positioned alongside platforms like Netflix and Amazon Prime in the Whale TV App Store, iDreamCTV will be accessible via Roku, Amazon Fire TV, Apple TV, and Android TV. Executives highlighted the move as a major milestone in monetizing iDreamCTV and previewed additional partnership announcements to come. To view the full…

Continue Reading

TuesdayMay 06, 2025 10:00 am

NetworkNewsBreaks – FAVO Capital Inc. (FAVO) Secures $8 Million Series A Investment to Fuel Growth and Nasdaq Uplisting Plans

FAVO Capital (OTC: FAVO), a fast-growing private credit platform specializing in revenue-based funding for small and medium-sized businesses, announced an $8 million Series A Preferred equity investment from Stewards Investment Capital. The funding will be used to expand direct SMB funding, restructure debt notes, and grow embedded lending partnerships, while also strengthening FAVO’s balance sheet ahead of a planned Nasdaq uplisting. Executives from both firms emphasized the scalability of the platform and their ongoing strategic partnership. To view the full press release, visit https://nnw.fm/euary About FAVO Capital Inc. FAVO Capital is a fast-growing alternative finance company specializing in flexible, technology-driven funding…

Continue Reading

MondayMay 05, 2025 10:40 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files Patent for Preservative-Free Ketamine Formulation

NRx Pharmaceuticals (NASDAQ: NRXP) a clinical-stage biopharma company, has filed a patent application for NRX-100, its preservative-free intravenous ketamine formulation targeting suicidal depression. The patent, which includes 20 claims, could provide exclusivity through 2045 if granted. NRX-100 is designed without benzethonium chloride or other preservatives linked to toxicity and has shown room temperature shelf stability—potentially qualifying it for FDA Orange Book listing. The filing supports the company’s NDA submission strategy and complements the FDA Fast Track Designation of companion drug NRX-101. To view the full press release, visit https://nnw.fm/qLeNE About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals is a clinical-stage biopharmaceutical company…

Continue Reading

MondayMay 05, 2025 9:30 am

NetworkNewsBreaks – VERAXA Biotech AG Launches Bispecific ADC Discovery Alliance with OmniAb (NASDAQ: OABI) 

VERAXA Biotech AG, a cancer therapy innovator, and proposed de-SPAC target of Voyager Acquisition Corp. (NASDAQ: VACH), announced a co-discovery alliance with OmniAb Inc. (NASDAQ: OABI) to jointly develop a novel bispecific antibody drug conjugate (“bsADC”) program targeting solid tumors. The collaboration combines OmniAb’s transgenic antibody discovery platform with VERAXA’s proprietary ADC linker and conjugation technology to create next-generation cancer therapeutics. Under the agreement, VERAXA will lead preclinical development using two selected cancer targets, while both companies will co-own the program and share future revenues from its advancement, licensing and commercialization. This marks VERAXA’s second major strategic initiative in six…

Continue Reading